MILRINONE LACTATE IN DEXTROSE 5% Drug Patent Profile

Which patents cover Milrinone Lactate In Dextrose 5%, and what generic alternatives are available?

Milrinone Lactate In Dextrose 5% is a drug marketed by Caplin, Eugia Pharma, Woodward, B Braun, Baxter Hlthcare, Gland, Hikma, and Hospira. and is included in ten NDAs.

The generic ingredient in MILRINONE LACTATE IN DEXTROSE 5% is milrinone lactate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Milrinone Lactate In Dextrose 5%

A generic version of MILRINONE LACTATE IN DEXTROSE 5% was approved as milrinone lactate by FRESENIUS KABI USA on May 28^th, 2002.

Summary for MILRINONE LACTATE IN DEXTROSE 5%

US Patents:	0
Applicants:	8
NDAs:	10

US Patents and Regulatory Information for MILRINONE LACTATE IN DEXTROSE 5%

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Caplin	MILRINONE LACTATE IN DEXTROSE 5%	milrinone lactate	INJECTABLE;INJECTION	219170-001	Sep 2, 2025	AP	RX	No	No
Baxter Hlthcare	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	075834-001	May 28, 2002	AP	RX	No	Yes
Eugia Pharma	MILRINONE LACTATE IN DEXTROSE 5%	milrinone lactate	INJECTABLE;INJECTION	209666-002	Sep 3, 2020	AP	RX	No	No
Hikma	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	075510-001	May 28, 2002		DISCN	No	No
Baxter Hlthcare	MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER	milrinone lactate	INJECTABLE;INJECTION	076259-001	Aug 8, 2002		DISCN	No	No